BRKR Stock Recent News
BRKR LATEST HEADLINES
Bruker (BRKR) came out with quarterly earnings of $0.53 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.64 per share a year ago.
Evaluate the expected performance of Bruker (BRKR) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Bruker's (BRKR) strong potential across the NANO and BioSpin segments bodes well for investors.
Bruker (BRKR) revenues continue to be driven by the strength of end markets, including academic, government and industrial.
NanoString announced Wednesday that it will be acquired by Bruker, ending the company's restructuring process that included a Chapter 11 bankruptcy plan.
Bruker's (BRKR) latest novel technology facilitates the widespread application of NMR in academic basic and clinical research.
Bruker Corporation (BRKR) outperforms the industry due to its strengthening portfolio and robust quarterly results.
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock?
Investors are upbeat about Bruker (BRKR) led by strong NANO group prospects and strong guidance.
Bruker (BRKR) advances CCS-Enabled 4D-Proteomics timsTOF solutions for immunopeptidomes and glycoproteomics at the US HUPO 2024.